| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |